Aug 24, 2020 5:00pm EDT NeuBase Therapeutic’s CEO, Dietrich A. Stephan, Ph.D., to Present at Tribe Public’s Presentation and Q&A Webinar Event on August 26, 2020
Aug 13, 2020 4:01pm EDT NeuBase Therapeutics Reports Financial Results for the Third Fiscal Quarter of 2020
Jul 30, 2020 4:01pm EDT NeuBase Therapeutics to Present at the BTIG Virtual Biotechnology Conference on Tuesday, August 11th
Jul 28, 2020 8:00am EDT NeuBase Therapeutics Strengthens Senior Management Team with Appointment of Industry Veteran William Mann, Ph.D., MBA as Chief Operating Officer
May 14, 2020 4:05pm EDT NeuBase Therapeutics Reports Financial Results for the Second Fiscal Quarter of 2020
Apr 30, 2020 4:05pm EDT NeuBase Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Apr 28, 2020 9:44am EDT NeuBase Therapeutics Announces Pricing of $31,500,000 Public Offering of Common Stock